Michael Rutz Sells 126,611 Shares of Sotera Health (NASDAQ:SHC) Stock

Sotera Health Company (NASDAQ:SHC) insider Michael Rutz sold 126,611 shares of the business’s stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $16.38, for a total value of $2,073,888.18. Following the sale, the insider owned 450,204 shares in the company, valued at approximately $7,374,341.52. The trade was a 21.95% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Sotera Health Trading Up 0.1%

NASDAQ SHC traded up $0.01 on Tuesday, hitting $16.40. 1,513,353 shares of the company were exchanged, compared to its average volume of 1,244,798. The company’s 50 day moving average price is $12.45 and its 200-day moving average price is $12.17. The company has a debt-to-equity ratio of 4.49, a current ratio of 2.47 and a quick ratio of 2.23. The firm has a market capitalization of $4.66 billion, a P/E ratio of 205.03 and a beta of 1.81. Sotera Health Company has a twelve month low of $9.53 and a twelve month high of $17.08.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings data on Friday, August 8th. The company reported $0.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.03. The firm had revenue of $294.34 million for the quarter, compared to the consensus estimate of $275.81 million. Sotera Health had a return on equity of 39.42% and a net margin of 2.14%.The business’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.19 EPS. Sotera Health has set its FY 2025 guidance at 0.750-0.820 EPS. Analysts predict that Sotera Health Company will post 0.61 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Sotera Health

A number of hedge funds have recently added to or reduced their stakes in the company. State of Wyoming increased its holdings in Sotera Health by 420.6% in the second quarter. State of Wyoming now owns 66,092 shares of the company’s stock worth $735,000 after buying an additional 53,397 shares during the last quarter. Vident Advisory LLC increased its holdings in Sotera Health by 23.9% in the second quarter. Vident Advisory LLC now owns 17,419 shares of the company’s stock worth $194,000 after buying an additional 3,364 shares during the last quarter. Tidal Investments LLC acquired a new position in Sotera Health in the second quarter worth approximately $199,000. Sculptor Capital LP increased its holdings in Sotera Health by 27.2% in the second quarter. Sculptor Capital LP now owns 11,500,000 shares of the company’s stock worth $127,880,000 after buying an additional 2,462,489 shares during the last quarter. Finally, Onex Canada Asset Management Inc. increased its holdings in Sotera Health by 61.6% in the second quarter. Onex Canada Asset Management Inc. now owns 414,095 shares of the company’s stock worth $4,605,000 after buying an additional 157,826 shares during the last quarter. Institutional investors and hedge funds own 91.03% of the company’s stock.

Wall Street Analysts Forecast Growth

SHC has been the topic of several recent analyst reports. Barclays restated an “overweight” rating on shares of Sotera Health in a report on Friday, August 8th. The Goldman Sachs Group upgraded Sotera Health from a “neutral” rating to a “buy” rating and upped their target price for the company from $14.00 to $17.00 in a report on Monday, May 5th. Finally, Wall Street Zen upgraded Sotera Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 16th. Four equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat, Sotera Health has a consensus rating of “Moderate Buy” and a consensus price target of $16.00.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.